| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT03140722 Details | 2021-02-21 Interventional | 2 | 2 | Epoetin Alfa Anemia Kidney Diseases Renal Insuffici… Dialysis-Depend… | Revised study design. The Study was closed by the Sponsor as it was determined that it was more appropriate to initiate a new study that would explore the broader population utilizing a modified dosing approach (rather than amending the current protocol design). | |||
| NCT02244112 Details | 2021-02-21 Interventional | 1 | 43 | Midazolam Neoplasms Advanced Non-Ce… | Why study stopped revised to "A program evaluation identified that the safety profile and
pharmacokinetic (PK) characteristics of the formulation used in all oprozomib studies required
further optimization and thus enrollment in OPZ009 was halted - | |||
| NCT00645229 Details | 2021-02-21 Interventional | 3 | 1 | Ziprasidone Psychotic Disor… Schizophrenia Schizoaffective… | Please see Detailed Description for termination reason. - | |||
| NCT00585312 NCT00393016 NCT00534040 Details | 2021-02-21 Interventional | 3 | 106 | Celecoxib Adenomatous Pol… Colorectal Neop… Nasopharyngeal … | See termination reason in detailed description. The study was early terminated and, due to the low number of participants, no efficacy analysis was performed. Only descriptive statistics was performed. | |||
| NCT00159757 Details | 2021-02-21 Interventional | 4 | - | Ziprasidone Schizophrenia | See Detailed Description for Termination Reason - | |||
| NCT02620904 Details | 2021-02-18 Interventional | 4 | 9 | Mifepristone Fetal Death Stillbirth Intrauterine Fe… | unable to recruit. Projected completion was 2018 however, enrollment and recruitment were
difficult. The study was terminated due to inability to enroll. Due to difficulty with recruitment the study was unable to be completed in the projected time frame. Despite efforts to enhance recruitment and extending the study duration very few persons were enrolled. Due to the limited enrollment no conclusions can be ascertained about the impact of mifepristone on the induction of labor in this setting. | |||
| NCT00640549 Details | 2021-02-18 Interventional | 4 | 41 | Atorvastatin Diabetes Mellit… Diabetes Mellit… Hyperlipidemias Hyperlipoprotei… Hyperlipidemia Non-Insulin Dep… | See termination reason in detailed description. - | |||
| NCT00040144 Details | 2021-02-18 Interventional | 2 | - | Dexelvucitabine Hepatitis Hepatitis A Hepatitis B Hepatitis B, Ch… Hepatitis, Chro… Chronic Hepatit… | Safety concerns - | |||
| NCT04077398 Details | 2021-02-16 Interventional | 4 | 0 | Ropivacaine Pain, Postopera… Analgesia Block Postoperative P… | covid interrupted initial start, then trainees involved finished program and no one took it on - | |||
| NCT03758729 Details | 2021-02-16 Interventional | 2 | 0 | Nivolumab Melanoma | Internal Issues - | |||
| NCT03574857 Details | 2021-02-16 Interventional | 4 | 5 | Chlorothiazide Metolazone Cardiovascular … Heart Failure Heart Failure A… Heart Failure W… | Low enrollment - | |||
| NCT03197025 Details | 2021-02-16 Interventional | 1 | 1 | Aldesleukin Interleukin-2 Carcinoma in Si… Carcinoma, Squa… Squamous Intrae… HPV-16 High Grade Squa… Human Papilloma… | The study was closed due to investigator discretion based on the lack of perceived clinical
activity observed in the study. - | |||
| NCT02973711 Details | 2021-02-16 Interventional | 1/2 | 0 | Nilotinib Leukemia, Myelo… Leukemia, Myelo… Leukemia, Chron… | lack of funding - | |||
| NCT04391868 Details | 2021-02-15 Interventional | 1 | 0 | Citric Acid Sildenafil Citr… Sodium Citrate Healthy | The project has been transferred to Viatris - | |||
| NCT03678480 Details | 2021-02-15 Interventional | 2 | 0 | Ursodeoxycholic… Bile Duct Disea… Biliary Tract D… Cholangitis Cholangitis, Sc… Digestive Syste… Gastrointestina… Adolescent Primary Scleros… | Corporate decision - | |||
| NCT03001349 Details | 2021-02-15 Interventional | 1 | 4 | Edotreotide Octreotide Endocrine Gland… Meningioma Multiple Endocr… Multiple Endocr… Neoplasms Neuroendocrine … Von Hippel-Lind… Metastatic Well… Neuroendocrine … Somatostatin Po… Von Hippel-Lind… | Per PI Request - | |||
| NCT02384954 Details | 2021-02-15 Interventional | 1/2 | 43 | Rituximab Lymphoma Lymphoma, B-Cel… Lymphoma, Non-H… Relapsed/Refrac… | Change in drug product development strategy. - | |||
| NCT00790478 Details | 2021-02-12 Interventional | 2 | 3 | Melatonin Colitis Colitis, Ulcera… Ulcer Ulcerative Coli… | - - | |||
| NCT04274907 Details | 2021-02-11 Interventional | 1 | 2 | Pembrolizumab Venetoclax Carcinoma, Non-… Lung Neoplasms Cancer Non Small Cell … | Company Decision - | |||
| NCT03841773 Details | 2021-02-11 Interventional | 3 | 192 | Cyclobenzaprine Stress Disorder… PTSD | Interim Analysis results - |